Using software and artificial intelligence, these companies are transforming the way we predict, detect, and treat conditions.
Lots of startups are focused on achieving success through the development of ideas and products that fit a clear market. But there are a number of private market companies looking to disrupt the world with their “game-changing” technologies and innovations.
In our Game Changers report, we identified 36 startups within 8 categories of innovation that are pushing their world-changing ideas to transform society today. One such category is drug discovery & diagnostics, comprised of companies employing new software and robotics techniques to improve medical R&D.
We’ve identified 5 startups within the space that are working to help predict and identify illnesses, develop treatments, and provide medical professionals with previously inaccessible data. The top drug discovery & diagnostics startups are Atomwise, Deep Genomics, Freenome, Elemental Machines, and Enlitic. These companies are all in different stages of development with funding ranging from $2.5M to $12M.
Atomwise uses advanced machine learning techniques for drug discovery and R&D. Early forays have included finding Ebola fighting drugs, and the company has prominent partnerships with research universities, Merck, Notable Labs, and Autodesk.
Total Funding: $6.1M
Select Investors: Khosla Ventures, Data Collective, AME Cloud Ventures, Draper Fisher Jurvetson, OS Fund, Y Combinator
Deep Genomics develops deep learning-based technology that can sift through hundreds of millions of previously known genetic mutations and predict what will happen to a cell when altered by variation, whether natural or therapeutic.
Total Funding: $3.7M
Select Investors: Bloomberg Beta, True Ventures
Freenome has developed a tech platform that merges genomics research and computational expertise to dynamically collect genetic material floating in the blood to develop early detection tests for cancer.
Total Funding: $6.4M
Select Investors: Andreessen Horowitz, Data Collective, Founders Fund
Elemental Machines develops a software simulator for the wet lab, speeding up drug discovery and identifying better methods for treating diseases in a shorter amount of time.
Total Funding: $2.5M
Select Investors: Founders Fund, Rock Health, Max Levchin
Enlitic uses machine learning to provide the tools that allow physicians to fully utilize the vast stores of siloed medical data collected today, regardless of what form they are in — such as medical images, doctors’ notes, and structured lab tests.
Total Funding: $12M
Select Investors: Amplify Partners, Capitol Health Partners, Data Collective
We get all the data from all of our reports from the CB Insights technology market intelligence platform. Want more data on game-changing startups? Log in to CB Insights or sign up for free below.